Press release from Companies: The Board of Directors of DanCann Pharma A/S convenes an Extraordinary General Meeting and proposes that the Meeting resolves a directed share issue

Press release from Companies: Impressive growth rate at DanCann Pharma A/S

Press release from Companies: DanCann Pharma A/S publishes Q1-2021 report

Press release from Companies: DanCann Pharma A/S publishes Q1-2021 report

Press release from Companies: DanCann Pharma A/S: The future is secured: The Pilot Programme has been made permanent

Press release from Companies: DanCann Pharma A/S: The future is secured: The Pilot Programme has been made permanent

Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain

Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain

Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial

Press release from Companies: DanCann Pharma A/S have signed a definitive distribution agreement with Tetra Bio-Pharma Inc. for the exclusive distribution of Reduvo™ Adversa® and Qixleef™ in Scandinavia and Germany

Press release from Companies: DanCann Pharma A/S har skrivit på ett slutgiltigt distributionsavtal med Tetra Bio-Pharma Inc. för exklusiv distribution av Reduvo™ Adversa® och Qixleef™ i Skandinavien och Tyskland

Press release from Companies: DanCann Pharma A/S appoints Christian Carlsen as new Board Member